基本信息
浏览量:59
职业迁徙
个人简介
Dr. Chun-Li Zhang received his Ph.D. in Genetics and Development from UT Southwestern Medical Center, where he worked on transcriptional control of muscle development and heart disease. Upon graduation in 2003, he conducted postdoctoral research as a HHMI Fellow of the Life Sciences Research Foundation in Dr. Ronald Evans’ laboratory at the Salk Institute, California. In collaboration with Dr. Fred Gage at the Salk, Dr. Zhang worked on adult neural stem cells and neurogenesis. He joined the faculty as Assistant Professor in 2008 and was promoted to Associate Professor with tenure in 2014 and Professor in 2018.
The major focus of his laboratory is on molecular and cellular mechanisms controlling adult neural stem cells, neurogenesis, regeneration of the nervous system, and cellular reprogramming for disease modeling and drug identification. Their discoveries were extensively reported by the news media, such as reprogramming in the adult brain (The Scientist Magazine, Nature Reviews Neuroscience, etc.), astrocyte reprogramming in the adult spinal cord (The Scientist Magazine, Neurology Today, Medical Daily, Breibart News Network, The Daily Texan, etc.), reprogramming NG2 glia for regeneration and recovery after spinal cord injury (Fiercebiotech, Eurekalert, etc.), modeling human amyotrophic lateral sclerosis (ALS) with adult-converted spinal motor neurons (MDLinx, Alzforum, The ALS Forum, Science Mission, ALS News Today, etc.), new findings on traumatic brain injury (Science Daily, News Medical, MD Magazine, etc.), and in vivo reprogramming of mature neurons (Discover Magazine, Science Magazine, Fierce Biotech, Genetic Engineering & Biotechnology News, Science Daily, EurekAlert, etc.). Their work on cell fate reprogramming in vivo was recognized as one of 2014's Big Advances in Science by The Scientist Magazine.
The major focus of his laboratory is on molecular and cellular mechanisms controlling adult neural stem cells, neurogenesis, regeneration of the nervous system, and cellular reprogramming for disease modeling and drug identification. Their discoveries were extensively reported by the news media, such as reprogramming in the adult brain (The Scientist Magazine, Nature Reviews Neuroscience, etc.), astrocyte reprogramming in the adult spinal cord (The Scientist Magazine, Neurology Today, Medical Daily, Breibart News Network, The Daily Texan, etc.), reprogramming NG2 glia for regeneration and recovery after spinal cord injury (Fiercebiotech, Eurekalert, etc.), modeling human amyotrophic lateral sclerosis (ALS) with adult-converted spinal motor neurons (MDLinx, Alzforum, The ALS Forum, Science Mission, ALS News Today, etc.), new findings on traumatic brain injury (Science Daily, News Medical, MD Magazine, etc.), and in vivo reprogramming of mature neurons (Discover Magazine, Science Magazine, Fierce Biotech, Genetic Engineering & Biotechnology News, Science Daily, EurekAlert, etc.). Their work on cell fate reprogramming in vivo was recognized as one of 2014's Big Advances in Science by The Scientist Magazine.
研究兴趣
论文共 93 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
ISCIENCEno. 2 (2024): 108895-108895
Wentong Hong,Pifang Gong,Xinjie Pan,Zhonggan Ren,Yitong Liu, Guibo Qi,Jun-Liszt Li,Wenzhi Sun,Woo-Ping Ge,Chun-Li Zhang,Shumin Duan,Song Qin
Neuroscience bulletinno. 1 (2024): 1-16
Frontiers in Neuroscience (2023): 1181816
bioRxiv : the preprint server for biology (2023)
Annual Review of Neuroscienceno. 1 (2023): 1-15
bioRxiv : the preprint server for biology (2023)
EBioMedicine (2023): 104531
Current opinion in genetics & development (2023): 102090-102090
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn